Michael Cerniglia

625 total citations
7 papers, 500 citations indexed

About

Michael Cerniglia is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Michael Cerniglia has authored 7 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 1 paper in Organic Chemistry. Recurrent topics in Michael Cerniglia's work include Cancer Immunotherapy and Biomarkers (4 papers), Melanoma and MAPK Pathways (4 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Michael Cerniglia is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Melanoma and MAPK Pathways (4 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Michael Cerniglia collaborates with scholars based in United States. Michael Cerniglia's co-authors include Mohammad Atefi, Begonya Comin-Anduix, Amanda Lassen, Antoni Ribas, Deborah J. Wong, Lídia Robert, David Foulad, Thomas G. Graeber, Earl Avramis and Bjoern Titz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Michael Cerniglia

7 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Cerniglia United States	6	342	264	171	68	63	7	500
Rodrigo Perez Pereira Brazil	6	467 1.4×	296 1.1×	155 0.9×	90 1.3×	35 0.6×	11	583
María de los Llanos Gil Spain	8	334 1.0×	253 1.0×	132 0.8×	138 2.0×	49 0.8×	15	518
Julien Bollard France	8	217 0.6×	241 0.9×	31 0.2×	120 1.8×	76 1.2×	16	457
Tammy Sobolik United States	8	213 0.6×	210 0.8×	103 0.6×	28 0.4×	23 0.4×	9	386
Matthew Sobo United States	7	253 0.7×	274 1.0×	52 0.3×	48 0.7×	92 1.5×	8	494
Liv Johannessen United States	8	152 0.4×	241 0.9×	34 0.2×	57 0.8×	30 0.5×	19	374
Tracy Lou United States	3	90 0.3×	209 0.8×	46 0.3×	57 0.8×	65 1.0×	3	334
Jodi Moriguchi United States	6	103 0.3×	220 0.8×	54 0.3×	54 0.8×	59 0.9×	13	335
Arun M. Unni United States	8	139 0.4×	259 1.0×	75 0.4×	99 1.5×	31 0.5×	12	406
Hélène Malka-Mahieu France	6	136 0.4×	387 1.5×	45 0.3×	32 0.5×	31 0.5×	10	456

Countries citing papers authored by Michael Cerniglia

Since Specialization

Citations

This map shows the geographic impact of Michael Cerniglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cerniglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cerniglia more than expected).

Fields of papers citing papers by Michael Cerniglia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Cerniglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cerniglia. The network helps show where Michael Cerniglia may publish in the future.

Co-authorship network of co-authors of Michael Cerniglia

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Cerniglia. A scholar is included among the top collaborators of Michael Cerniglia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Cerniglia. Michael Cerniglia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Cerniglia, Michael, et al.. (2022). Treatment of Metastatic Disease with Immune Checkpoint Inhibitors Nivolumab and Pembrolizumab: Effect of Performance Status on Clinical Outcomes. SHILAP Revista de lepidopterología. 5(2). 37–42. 5 indexed citations

2.

Cerniglia, Michael, et al.. (2022). Response to PD-1 inhibitor after progression on PD-L1 inhibitor in advanced HCC. BMJ Case Reports. 15(8). e250009–e250009. 2 indexed citations

3.

Cerniglia, Michael, Joanne Xiu, Axel Grothey, et al.. (2019). Association of DNA damage response and repair genes (DDR) mutations and microsatellite instability (MSI), PD-L1 expression, tumor mutational burden (TMB) in gastroesophageal cancers.. Journal of Clinical Oncology. 37(4_suppl). 60–60. 6 indexed citations

4.

Atefi, Mohammad, Bjoern Titz, Earl Avramis, et al.. (2015). Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma. Molecular Cancer. 14(1). 27–27. 51 indexed citations

5.

Atefi, Mohammad, Earl Avramis, Amanda Lassen, et al.. (2014). Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma. Clinical Cancer Research. 20(13). 3446–3457. 285 indexed citations

6.

Wong, Deborah J., Lídia Robert, Mohammad Atefi, et al.. (2014). Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Molecular Cancer. 13(1). 194–194. 85 indexed citations

7.

Lassen, Amanda, Mohammad Atefi, Lídia Robert, et al.. (2014). Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma. Molecular Cancer. 13(1). 83–83. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact